Patient Files: Chronic Myeloid Leukaemia
Katie Ruane was just 22 when diagnosed with CML, and while drugs keep the disease in remission it still takes a huge toll on her life
PharmaTimes Magazine - Clinical Researcher (Americas)
Magazine highlights
View more from the latest edition
Putting our heads together
NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key
The dementia dilemma
The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure
Genome sequencing: unlocking personalised medicine
Home DNA tests are now common, but using genome sequencing to personalise drugs still has some way to go
How Brexit will impact the supply chain
The regulatory impacts of Brexit could be far-reaching, so now is not the time to take a ‘wait and see’ approach
Health apps: Working smarter, not just harder
The myriad ways digital tools could change everything for pharma and the NHS
Health apps: The litmus test
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Patient centricity through the shop window
Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
